Almac Group’s diagnostics business unit has launched its advanced version of next generation sequencing (NGS) data analysis services.  These latest enhancements to Almac’s service portfolio include a comprehensive range of NGS solutions from professional study design to sample processing and expert data analysis for DNA and RNA samples. 

"By expanding our services to include this range of DNA and RNA-sequencing analysis, we are empowering our customers with the most cutting edge technologies, opening new avenues within their research and boosting the potential for advancement of human health in a variety of disease settings,” said Michael Sloan, vice president of business development for Almac.

The enhanced services are customizable and are available on a standalone basis or in combination with Almac’s established bioinformatics offerings in the areas of biomarker and drug discovery, biological analysis and development and diagnostic product development.